Historical salary details - Mr. Ian F. Smith, Executive Chairman of the Board, Solid Biosciences Inc
Mr. Ian F. Smith is the Executive Chairman of the Board of Solid Biosciences Inc. They also hold 2 other positions in Foghorn Therapeutics Inc and Stoke Therapeutics Inc.
Mr. Ian F. Smith
Executive Chairman of the Board
$ 480.6 K
Gross Remuneration
-
Current Company
Solid Biosciences Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Solid Biosciences Inc | Executive Chairman of the Board | 374.2 K | -54.8 % |
| 2024 | Foghorn Therapeutics Inc | Independent Director | 106.4 K | -24.8 % |
| 2024 | Stoke Therapeutics Inc | Director and Interim Chief Executive Officer | - | - |
| 2023 | Solid Biosciences Inc | Executive Chairman of the Board | 828.6 K | 29.9 % |
| 2023 | Stoke Therapeutics Inc | Independent Director | 394.0 K | - |
| 2023 | Foghorn Therapeutics Inc | Independent Director | 141.6 K | -27.9 % |
| 2022 | Solid Biosciences Inc | Executive Chairman of the Board | 637.8 K | -76.6 % |
| 2022 | Foghorn Therapeutics Inc | Director | 196.4 K | -34.5 % |
| 2021 | Solid Biosciences Inc | Executive Chairman of the Board | 2.7 M | 439.3 % |
| 2021 | Foghorn Therapeutics Inc | Director | 299.7 K | - |
| 2020 | Solid Biosciences Inc | Chairman of the Board | 504.6 K | - |
| 2020 | Foghorn Therapeutics Inc | Director | - | - |
| 2019 | Acorda Therapeutics Inc | Independent Director | - | - |
| 2019 | Solid Biosciences Inc | Independent Director | - | - |
| 2019 | Infinity Pharmaceuticals Inc. | Independent Director | - | - |
| 2018 | Acorda Therapeutics Inc | Independent Director | 296.4 K | 73.8 % |
| 2018 | Infinity Pharmaceuticals Inc. | Independent Director | 87.1 K | -31.6 % |
| 2017 | Acorda Therapeutics Inc | Independent Director | 170.5 K | -33.1 % |
| 2017 | Infinity Pharmaceuticals Inc. | Independent Director | 127.4 K | 59.0 % |
| 2016 | Acorda Therapeutics Inc | Independent Director | 254.8 K | -6.9 % |
| 2016 | Infinity Pharmaceuticals Inc. | Independent Director | 80.1 K | -52.9 % |
| 2015 | Acorda Therapeutics Inc | Independent Director | 273.7 K | 19.0 % |
| 2015 | Infinity Pharmaceuticals Inc. | Independent Director | 170.2 K | -4.8 % |
| 2014 | Acorda Therapeutics Inc | Independent Director | 229.9 K | -1.1 % |
| 2014 | Infinity Pharmaceuticals Inc. | Independent Director | 178.8 K | -25.4 % |
| 2013 | Infinity Pharmaceuticals Inc. | Independent Director | 239.7 K | 118.7 % |
| 2013 | Acorda Therapeutics Inc | Independent Director | 232.5 K | 28.8 % |
| 2012 | Acorda Therapeutics Inc | Independent Director | 180.5 K | -22.8 % |
| 2012 | Infinity Pharmaceuticals Inc. | Independent Director | 109.6 K | 60.7 % |
| 2011 | Acorda Therapeutics Inc | Independent Director | 233.8 K | -13.5 % |
| 2011 | Infinity Pharmaceuticals Inc. | Independent Director | 68.2 K | 1.4 % |
| 2010 | Acorda Therapeutics Inc | Director | 270.2 K | 46.6 % |
| 2010 | Infinity Pharmaceuticals Inc. | Independent Director | 67.3 K | 5.9 % |
| 2009 | Acorda Therapeutics Inc | Director | 184.3 K | -10.5 % |
| 2009 | Infinity Pharmaceuticals Inc. | Director | 63.5 K | 20.4 % |
| 2008 | Acorda Therapeutics Inc | Director | 205.9 K | 66.7 % |
| 2008 | Infinity Pharmaceuticals Inc. | Director | 52.8 K | - |
| 2007 | Acorda Therapeutics Inc | Director | 123.5 K | - |
| 2007 | Infinity Pharmaceuticals Inc. | Director | - | - |
| 2006 | Acorda Therapeutics Inc | Director | - | - |
| 2006 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Offic | - | - |